Nucleome Therapeutics Limited

Nucleome Therapeutics is a biotechnology company focused on decoding the regulatory genome to develop precision medicines. Their technology platform aims to enhance the scale and precision of genetics-led drug discovery, particularly for complex diseases such as autoimmune disorders.
  • Precision medicines
  • Genetics-led drug discovery
  • Biologics and small molecule approaches

Size
Small
Phone
N/A
Email
N/A
Locations
The Schrödinger Building, The Oxford Science Park, Heatley Rd, OX4 4GE
01865346060
9:00 - 18:00
Digital Popularity
Social Media
Competitors
Exscientia
Exscientia is a technology-driven company focused on AI drug discovery, aiming to revolutionise the pharmaceutical industry through precision medicine.
GeneOmics Solutions
GeneOmics Solutions is dedicated to early diagnosis and treatment through the integration of multi-omics data for precision medicine.
Company Details
Nucleome Therapeutics Limited is operated by Nucleome Therapeutics Limited and is a Active company incorporated on 17 July 2019 with the registered office located in Oxford, Oxfordshire. Nucleome Therapeutics Limited was registered 6 years ago.

Status
Active
Size
Unreported
Directors
10
Age
6 years old
Employees
44
Turnover
£156K
Total Assets
£24.34M
Cash in Bank
£12.29M
Total Liabilities
-£1.31M

Director • British,irish • Lives in UK • Born in Sep 1968
Director • British • Lives in UK • Born in Jun 1996
Director • British • Lives in UK • Born in Jun 1957
Director • Lives in England • Born in Apr 1971
Director • American • Lives in United States • Born in Jun 1975
Director • American • Lives in United States • Born in Mar 1962
Teams
All
45
Management
16
Research
14
IT
3
Administration
3
Human Resources
3
Accounting
2
Senior Vice President Operations • Joined Sep 2024
Vice President, Drug Discovery • Joined Jul 2024
Senior Vice President, Data Science And Informatics • Joined Apr 2023
Chief Executive Officer • Joined Jul 2024
Executive Assistant To CEO And Board • Joined Apr 2024
Principal Scientist • Joined Feb 2023
Principal Scientist • Joined Oct 2023
Chief People Officer • Joined Jan 2025
Principal Computational Biologist • Joined Mar 2024
Co-Founder And Consultant • Joined Aug 2019
Senior Vice President Operations • Joined Sep 2024
Chief Executive Officer • Joined Jul 2024
Executive Assistant To CEO And Board • Joined Apr 2024
Principal Scientist • Joined Feb 2023
Principal Scientist • Joined Oct 2023
Chief People Officer • Joined Jan 2025
Co-Founder And Consultant • Joined Aug 2019
HR Business Partner • Joined Jan 2025
Information Technology Lead • Joined Jul 2022
Laboratory Manager • Joined Apr 2023
Principal Scientist • Joined Feb 2023
Principal Scientist • Joined Oct 2023
Laboratory Manager • Joined Apr 2023
Research Assistant • Joined Oct 2022
Senior Scientist • Joined Apr 2024
Senior Scientist • Joined Jun 2023
Senior Bioinformatician • Joined Nov 2022
Senior Scientist • Joined Jan 2024
Senior Bioinformatician • Joined Jun 2023
Scientist • Joined Feb 2022
Information Technology Lead • Joined Jul 2022
Senior ML Engineer • Joined Feb 2024
Senior Machine Learning Engineer • Joined Dec 2021
Executive Assistant To CEO And Board • Joined Apr 2024
HR Business Partner • Joined Jan 2025
Finance Assistant • Joined Mar 2024
Finance Assistant • Joined Mar 2024
Financial Controller • Joined Aug 2024
Chief People Officer • Joined Jan 2025
HR Business Partner • Joined Jan 2025
Talent Manager • Joined Mar 2021
View 45 members